• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [1526 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2004 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Assessment of screening for cytomegalovirus (CMV) infection in pregnant women in France
2004 Blue Cross Blue Shield Association (BCBS) Vertebral assessment using dual-energy x-ray absorptiometry for osteoporotic fracture risk assessment
2004 HAYES, Inc. Breast ductal lavage and fiberoptic ductoscopy for breast cancer diagnosis and screening
2004 HAYES, Inc. Computer-assisted screening methods for detecting cervical cancer
2004 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) PET-CT: indications, systematic review and meta-analysis IPE-04/41 (Public report)
2004 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Should the French breast cancer screening programme be extended to women aged 40-49? Update
2004 Canadian Task Force on Preventive Health Care (CTFPHC) Screening for depression in primary care: updated recommendations from the Canadian Task Force on Preventive Health Care
2004 Agency for Healthcare Research and Quality (AHRQ) Screening for bladder cancer
2004 Health Council of the Netherlands Gezondheidsraad (GR) Screening for type 2 diabetes
2004 Health Council of the Netherlands Gezondheidsraad (GR) Prenatal screening (2) - Down's syndrome, neural tube defects
2004 Health Council of the Netherlands Gezondheidsraad (GR) [Screening for chlamydia]
2004 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Mammography screening in the county of Funen 1993 - 1997. An HTA report]
2004 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Evaluation of photodynamic therapy for the treatment of exudative age-related macular degeneration (ARMD) with subfoveal neovascularization
2004 Medical Services Advisory Committee (MSAC) Faecal occult blood testing for population health screening
2004 VA Technology Assessment Program (VATAP) Screening colonoscopy by mid-level practitioners
2004 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [The screening of congenital adrenal hyperplasia. Applicability in Galicia]
2004 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Assessment of screening programmes - methodology
2004 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Neonatal screening of hemoglobinopathies]
2004 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Neonatal cystic fibrosis screening]
2004 Center for Medical Technology Assessment (CMT) Screening for abdominal aortic aneurysm - a health economic assessment
2004 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) PAP-test for the screening of cervical carcinoma: impact of different examination intervals
2004 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Screening of the hearing of newborns - systematic review of medical efficacy and economic efficiency
2004 ECRI Pap smear plus speculoscopy for cervical cancer screening
2004 Adelaide Health Technology Assessment (AHTA) MRI screening for breast cancer in genetically high-risk women
2004 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Computer aided detection systems in mammography: a breast cancer detection tool for women attending screening and/or diagnostic mammography services.
2004 Adelaide Health Technology Assessment (AHTA) The detection of diabetic retinopathy utilising retinal photography in rural and remote areas in Australia.
2004 Adelaide Health Technology Assessment (AHTA) MRI screening for breast cancer: screening for breast cancer with MRI in genetically high-risk women
2004 Adelaide Health Technology Assessment (AHTA) Computer aided detection systems in mammography
2004 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Screening for hearing loss in high risk babies
2004 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Screening for obesity in young population
2004 HAYES, Inc. High-sensitivity C-reactive protein testing for coronary artery disease screening of asymptomatic individuals
2004 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Screening for breast cancer]
2004 Adelaide Health Technology Assessment (AHTA) Computer Aided Detection Systems in Mammography: A breast cancer detection tool for women attending screening and/or diagnostic mammography services
2003 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Diagnosis and treatment of sleep apnea - systematic review of diagnostics, therapy, and cost-effectiveness
2003 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Evaluation of techniques for detecting breast implant rupture]
2003 NIHR Health Technology Assessment programme A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
2003 NIHR Health Technology Assessment programme The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model
2003 NIHR Health Technology Assessment programme First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)
2003 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Multislice/spiral computed tomography for screening for coronary artery disease
2003 Institute for Clinical Systems Improvement (ICSI) Ultrasound cervical length for the prediction of preterm labor
2003 Centre for Clinical Effectiveness (CCE) Dipstick urinalysis for screening of childhood urinary tract infection
2003 Agency for Healthcare Research and Quality (AHRQ) Diffusion and dissemination of evidence-based cancer control interventions
2003 Agency for Healthcare Research and Quality (AHRQ) Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness
2003 NIHR Health Technology Assessment programme Screening for fragile X syndrome: a literature review and modelling study
2003 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) First-trimester prenatal screening for Down syndrome and other aneuploidies
2003 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Bone mineral density screening
2003 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Multi-slice/helical computed tomography for lung cancer screening
2003 New Zealand Health Technology Assessment (NZHTA) What is the prognostic value of calcium scoring in screening asymptomatic populations for cardiovascular disease? Evidence Tables
2003 Institute for Clinical Systems Improvement (ICSI) Liquid-based cervical cytology
2003 NIHR Health Technology Assessment programme The role of modelling in prioritising and planning clinical trials
2003 Agency for Healthcare Research and Quality (AHRQ) Screening for type 2 diabetes mellitus
2003 Agency for Healthcare Research and Quality (AHRQ) Screening for dementia
2003 Agency for Healthcare Research and Quality (AHRQ) Screening for gestational diabetes mellitus
2003 Agency for Healthcare Research and Quality (AHRQ) Screening for high blood pressure
2003 Malaysian Health Technology Assessment Unit (MHTAU) Management of thalassaemia
2003 NIHR Health Technology Assessment programme The value of digital imaging in diabetic retinopathy
2003 Agency for Healthcare Research and Quality (AHRQ) Screening and interventions for overweight and obesity in adults
2003 Medical Services Advisory Committee (MSAC) Computer-assisted image analysis for cervical screening
2003 Medical Services Advisory Committee (MSAC) Diagnostic and therapeutic modalities for coronary artery disease
2003 Centre for Clinical Effectiveness (CCE) Is a digital rectal examination necessary in conscious trauma patients with no clinical evidence of a pelvic fracture or neurological abnormality?
2003 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Principles of screening for type 2 diabetes
2003 NIHR Health Technology Assessment programme Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling
2003 NIHR Health Technology Assessment programme The impact of screening on future health-promoting behaviours and health beliefs: a systematic review
2003 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Liquid-based cytology and human papillomavirus testing in cervical cancer screening
2003 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Molecular diagnosis for hereditary cancer predisposing syndromes: genetic testing and clinical impact
2003 Institute for Clinical Systems Improvement (ICSI) Whole-body computed tomography as a screening test
2003 Medical Services Advisory Committee (MSAC) Human papillomavirus testing for cervical screening
2003 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Assessment of screening for Chlamydia trachomatis infection of the lower genitourinary tract in France
2003 The Swedish Council on Health Technology Assessment (SBU) Osteoporosis - prevention, diagnosis and treatment
2003 Blue Cross Blue Shield Association (BCBS) Magnetic resonance imaging of the breast in screening women considered to be at high genetic risk of breast cancer
2003 Institute for Clinical Systems Improvement (ICSI) Magnetic resonance imaging (MRI) for the detection of breast abnormalities
2003 Agency for Healthcare Research and Quality (AHRQ) A comparison of the cost-effectiveness of fecal occult blood tests with different test characteristics in the context of annual screening in the Medicare population
2003 Agency for Healthcare Research and Quality (AHRQ) Screening for asymptomatic coronary artery disease: a systematic review for the U.S. Preventive Services Task Force
2003 The Swedish Council on Health Technology Assessment (SBU) Screening for abdominal aortic aneurysms - early assessment briefs (Alert)
2003 The Swedish Council on Health Technology Assessment (SBU) Computed tomography in screening for lung cancer. Version 2.0 - early assessment briefs (Alert)
2003 Agency for Healthcare Research and Quality (AHRQ) Effect of supplemental use of antioxidants vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cancer
2003 HAYES, Inc. Computer-aided detection for screening mammography
2003 HAYES, Inc. Helical computed tomography for lung cancer screening
2003 HAYES, Inc. Prostate-specific antigen testing for screening and early detection of prostate cancer
2003 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Implantable spinal infusion devices for chronic pain and spasticity: an accelerated systematic review
2003 Canadian Task Force on Preventive Health Care (CTFPHC) Screening for lung cancer: updated recommendations from the Canadian Task Force on Preventive Health Care
2003 Medical Advisory Secretariat (MAS) Neonatal screening of inborn errors of metabolism using tandem mass spectrometer: an evidence-based analysis
2003 Medical Advisory Secretariat (MAS) Implantable cardioverter defibrillator - prophylactic use
2003 Medical Advisory Secretariat (MAS) Computed tomographic colonography: an evidence-based analysis
2003 Canadian Task Force on Preventive Health Care (CTFPHC) Prevention of falls in long-term care facilities: systematic review and recommendations
2003 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) The use of thermal imaging devices in screening for fever
2003 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Type 2 diabetes. Health technology assessment of screening, diagnosis and treatment - systematic review]
2003 Danish Institute for Health Services Research (DSI) A health technology assessment (HTA) is undertaken focusing on primary screening, screening for complications, pharmacological and non-pharmacological treatment of diabetes type II. The HTA focuses primarily on the efficacy and the cost-effectiveness of the procedures. Participants in the project: DSI and DACEHTA. CEMTV rapport
2003 Institute for Clinical Effectiveness and Health Policy (IECS) Confocal laser scanning ophthalmoscopy/tomography forglaucoma
2003 Institute of Technology Assessment (ITA) Colorectal cancer screening: Integrating coloscopy/sigmoidoscopy into the Austrian preventive medical check up. An unsystematic review
2003 Quality Improvement Scotland (NHS QIS ) The use of liquid-based cytology for cervical screening (review)
2003 Canadian Task Force on Preventive Health Care (CTFPHC) Screening for type 2 diabetes to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care
2003 ECRI Automated thin-layer slide preparation systems for cervical cancer screening
2003 Adelaide Health Technology Assessment (AHTA) Population genetic screening for haemochromatosis: identifying asymptomatic "at risk" homozygous individuals
2003 Adelaide Health Technology Assessment (AHTA) Ultrasound screening for hip dysplasia: a new screening programme for the early detection of hip dysplasia in neonates
2003 Adelaide Health Technology Assessment (AHTA) Virtual bronchoscopy: non-invasive CT scanning technique for screening patients with possible tracheobronchial disease or obstruction
2003 Adelaide Health Technology Assessment (AHTA) Virtual colonoscopy: non-invasive CT scanning technique for screening patients with possible bowel disease
2003 ECRI Ultrasound screening of normal-risk women for prevention of postterm pregnancy
2003 Medical Services Advisory Committee (MSAC) Cervical cancer screening (#12c)
2003 National Institute for Health and Care Excellence (NICE) Guidance on the use of liquid-based cytology for cervical screening. NICE technology appraisal guidance 69